Literature DB >> 8138264

Assessment of hepatic iron overload in thalassemic patients by magnetic resonance spectroscopy.

R M Dixon1, P Styles, F N al-Refaie, G J Kemp, S M Donohue, B Wonke, A V Hoffbrand, G K Radda, B Rajagopalan.   

Abstract

The transverse relaxation time of water protons is shortened by the presence of iron. This shortening depends on the amount and the environment of iron in the sample. We have developed a method for measuring short transverse relaxation time noninvasively by magnetic resonance spectroscopy. To evaluate magnetic resonance spectroscopy as a means of assessing hepatic iron content in patients with transfusional iron overload, we compared the results obtained with this method with those obtained by other means of assessing total body iron content. The correlation between the liver biopsy iron concentration and 1/transverse relaxation time was highly significant (r = 0.95, p < 0.004, n = 6) for iron loads up to 3% dry weight. The correlation between serum ferritin and 1/transverse relaxation time was also significant, but the correlation coefficient was much lower (r = 0.67, p < 0.002, n = 20). The correlation between 24-hr urinary iron excretion and 1/transverse relaxation time was not significant, nor was that between AST and 1/transverse relaxation time. We conclude that magnetic resonance spectroscopic determination of the transverse relaxation time of hepatic water is an accurate method of measuring liver iron content, especially when the iron content is below 3%. Because it is a noninvasive method that is associated with negligible side effects, it could provide clinicians with an excellent means of assessing the effectiveness of the various therapeutic strategies used in the management of patients with iron overload.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8138264

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  7 in total

1.  MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients.

Authors:  John C Wood; Cathleen Enriquez; Nilesh Ghugre; J Michael Tyzka; Susan Carson; Marvin D Nelson; Thomas D Coates
Journal:  Blood       Date:  2005-04-28       Impact factor: 22.113

Review 2.  Quantification of liver iron with MRI: state of the art and remaining challenges.

Authors:  Diego Hernando; Yakir S Levin; Claude B Sirlin; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2014-03-03       Impact factor: 4.813

3.  Myocardial iron deposition in beta-thalassemia studied by magnetic resonance imaging.

Authors:  S I Mavrogeni; T Maris; A Gouliamos; L Vlahos; D T Kremastinos
Journal:  Int J Card Imaging       Date:  1998-04

4.  Assessment of cardiac iron by MRI susceptometry and R2* in patients with thalassemia.

Authors:  Zhiyue J Wang; Roland Fischer; Zili Chu; Donald H Mahoney; Brigitta U Mueller; Raja Muthupillai; Ellen B James; Rajesh Krishnamurthy; Taylor Chung; Eric Padua; Elliott Vichinsky; Paul Harmatz
Journal:  Magn Reson Imaging       Date:  2010-01-12       Impact factor: 2.546

5.  Complex confounder-corrected R2* mapping for liver iron quantification with MRI.

Authors:  Diego Hernando; Rachel J Cook; Naila Qazi; Colin A Longhurst; Carol A Diamond; Scott B Reeder
Journal:  Eur Radiol       Date:  2020-08-12       Impact factor: 5.315

Review 6.  Treating iron overload in patients with non-transfusion-dependent thalassemia.

Authors:  Ali T Taher; Vip Viprakasit; Khaled M Musallam; M Domenica Cappellini
Journal:  Am J Hematol       Date:  2013-03-08       Impact factor: 10.047

7.  T2 relaxation time study of iron overload in b-thalassemia.

Authors:  S I Mavrogeni; E D Gotsis; V Markussis; N Tsekos; C Politis; E Vretou; D Kermastinos
Journal:  MAGMA       Date:  1998-08       Impact factor: 2.533

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.